Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-24-043839
Filing Date
2024-11-06
Accepted
2024-11-06 16:25:26
Documents
16
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm   iXBRL 10-K/A 128704
2 ex4-1.htm EX-4.1 30015
3 ex31-1.htm EX-31.1 6005
4 ex31-2.htm EX-31.2 5887
  Complete submission text file 0001493152-24-043839.txt   413299

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE brtx-20231231.xsd EX-101.SCH 3033
6 XBRL LABEL FILE brtx-20231231_lab.xml EX-101.LAB 36884
7 XBRL PRESENTATION FILE brtx-20231231_pre.xml EX-101.PRE 24158
18 EXTRACTED XBRL INSTANCE DOCUMENT form10-ka_htm.xml XML 8655
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

EIN.: 301341024 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37603 | Film No.: 241431430
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)